Exploring Novel Biologically-Relevant Chemical Space Through Artificial Intelligence: The NCATS ASPIRE Program.

Journal: Frontiers in robotics and AI
Published Date:

Abstract

In recent years, artificial intelligence (AI)/machine learning (ML; a subset of AI) have become increasingly important to the biomedical research community. These technologies, coupled to big data and cheminformatics, have tremendous potential to improve the design of novel therapeutics and to provide safe and effective drugs to patients. A National Center for Advancing Translational Sciences (NCATS) program called A Specialized Platform for Innovative Research Exploration (ASPIRE) leverages advances in AI/ML, automated synthetic chemistry, and high-throughput biology, and seeks to enable translation and drug development by catalyzing exploration of biologically active chemical space. Here we discuss the opportunities and challenges surrounding the application of AI/ML to the exploration of novel biologically relevant chemical space as part of ASPIRE.

Authors

  • Katharine K Duncan
    National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States.
  • Dobrila D Rudnicki
    National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States.
  • Christopher P Austin
    National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States.
  • Danilo A Tagle
    National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States.

Keywords

No keywords available for this article.